-
UPCC 17419: A Phase 1b-2 Open-Label Study of JNJ-68284528 a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BCMA ...
The main purpose of this study is to investigate the use of a new, experimental drug called JNJ-68284528 in subjects ...
Exact
Phase 
-
UPCC 37420 Phase 2 Study of Belantamab Mafodotin As Pre- and Post- Autologous Stem Cell Transplant Consolidation and Maintenance For ...
The research study is being conducted to see if combining an investigational drug, called belantamab mafodotin, with standard-of-care autologous stem ...
Exact
Phase
Showing - of trials